Company Results (links open in a new window)
|
Date (document was filed at Companies House)
|
Type
|
Description (of the document filed at Companies House)
|
View / Download (PDF file, link opens in new window)
|
|
19 Sep 2024 |
TM01 |
Termination of appointment of William John Robert Fleming as a director on 18 September 2024
|
|
|
03 Jul 2024 |
AA01 |
Current accounting period extended from 30 June 2024 to 31 December 2024
|
|
|
24 May 2024 |
AD03 |
Register(s) moved to registered inspection location 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT
|
|
|
24 May 2024 |
AD02 |
Register inspection address has been changed to 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT
|
|
|
18 Mar 2024 |
CS01 |
Confirmation statement made on 7 February 2024 with updates
|
|
|
26 Sep 2023 |
AA |
Total exemption full accounts made up to 30 June 2023
|
|
|
15 Mar 2023 |
MA |
Memorandum and Articles of Association
|
|
|
14 Mar 2023 |
RESOLUTIONS |
Resolutions
-
RES01 ‐
Resolution of adoption of Articles of Association
|
|
|
09 Mar 2023 |
TM01 |
Termination of appointment of Simon Kerry as a director on 22 February 2023
|
|
|
09 Mar 2023 |
TM01 |
Termination of appointment of Nicholas George Dixon-Clegg as a director on 22 February 2023
|
|
|
09 Mar 2023 |
AP01 |
Appointment of Mr William John Robert Fleming as a director on 22 February 2023
|
|
|
28 Feb 2023 |
AA01 |
Current accounting period extended from 28 February 2023 to 30 June 2023
|
|
|
23 Feb 2023 |
CS01 |
Confirmation statement made on 7 February 2023 with updates
|
|
|
23 Feb 2023 |
CH01 |
Director's details changed for Prof Nicholas Barrie La Thangue on 23 February 2023
|
|
|
23 Feb 2023 |
CH01 |
Director's details changed for Dr Simon Kerry on 23 February 2023
|
|
|
30 Jan 2023 |
PSC05 |
Change of details for Celleron Therapeutics Holdings Limited as a person with significant control on 26 January 2023
|
|
|
25 Jan 2023 |
TM02 |
Termination of appointment of Douglas Mcdonald as a secretary on 22 December 2022
|
|
|
24 Jan 2023 |
TM01 |
Termination of appointment of Chan-Hee Park as a director on 22 December 2022
|
|
|
17 Jan 2023 |
SH01 |
Statement of capital following an allotment of shares on 22 December 2022
|
|
|
16 Jan 2023 |
PSC07 |
Cessation of Oxford Sciences Innovation Plc as a person with significant control on 22 December 2022
|
|
|
16 Jan 2023 |
PSC02 |
Notification of Celleron Therapeutics Holdings Limited as a person with significant control on 22 December 2022
|
|
|
29 Nov 2022 |
RP04SH01 |
Second filing of a statement of capital following an allotment of shares on 22 September 2022
|
|
|
24 Oct 2022 |
SH01 |
Statement of capital following an allotment of shares on 22 September 2022
-
ANNOTATION
Clarification a second filed SH01 was registered on 29.11.2022.
|
|
|
19 Oct 2022 |
SH01 |
Statement of capital following an allotment of shares on 22 September 2022
|
|
|
19 Oct 2022 |
MA |
Memorandum and Articles of Association
|
|